Casdin Capital, LLC sold $12.2M of Biolife Solutions (BLFS)

Executed Aug 15 2025, disclosed Aug 21 2025, 6 days later, against a two-business-day limit.

Value, as filed

$12.2M

500,000 sh × $24.40

Executed

Aug 15 2025

the trade date, as filed

Disclosed

Aug 21 2025

6 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CL Casdin Capital, LLC Director profile →

Casdin Capital, LLC (Director) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in GeneDx Holdings Corp. (WGS). Across 2 priced purchase filings, the average 21-session return was +36.2% from execution and +32.5% from disclosure (delay-adjusted; derived). The largest single filing was $21.5M of WGS (500,000 sh across 3 lots, as filed), executed May 18.

The name

BLFS BLFS BLFS · 24 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→